Professional Pharmaceutical Care Services. A case report

• Published in: Farmacéuticos comunitarios Vol. 16; no. 4; p. 88
• Main Authors: Dévora Gutiérrez, Sandra, Morales Marrero, Chaxiraxi, Herrera Ramos, Patricia, Vera Peña, Adama, Oliva Martin, Alexis M, Abdala Kuri, Susana
• Format: Journal Article
• Language: Spanish
• Published: Spain 15-10-2024
• Subjects: Accidental Falls; Aged; Female; Forearm Injuries - drug therapy; Humans; Medication Adherence; Pharmaceutical Services; Cardiovascular disease; Pharmaceutical care; SPD
• ISSN: 2173-9218; 2173-9218
• DOI: 10.33620/FC.2173-9218.(2024).25

A 73-year-old woman, independent, with a medical history of psychopathology under treatment and non-compliant. After a fall, he suffered a forearm fracture and, in this context, abuse of psychoactive drugs and non-steroidal antiinflammatory drugs was suspected.
The state of the patient's situation was evaluated, and an abuse of the hypnotic-anxiolytic treatment was observed, which could be related to her recent forearm fracture. His poor therapeutic adherence led to poor control of his health problems and the appearance of possible Negative Outcomes Associated with Medication (NOM).
He was referred to his primary care physician with a pharmacist consultation report, indicating the possible NMRs and therapeutic alternatives in antihypertensive and antidepressant treatment.
The family physician related the fall and subsequent forearm fracture, as well as the decompensation of his basal pathology, with therapeutic noncompliance. The proposal for pharmaceutical intervention was accepted, monitoring blood pressure for its corresponding dosage readjustment, bupropion was withdrawn, a gradual deprescription of benzodiazepine doses began, and the antiinflammatory was replaced by analgesics. Consequently, the patient significantly improved her cardiovascular health and her quality of life, in addition to increasing her personal autonomy.
Multidisciplinary communication between health professionals allows better control of cardiovascular disease and optimization of pharmacotherapy and health resources, contributing to improving their state of health.